SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Income Statement
Fiscal Year Start:
Oct 1
Revenues in 2024
$16,661,336
Program Services
72%
Contributions
16%
Other
7%
Investments
3%
Government Grants
2%
Fundraising Events
<1%
Membership Dues
0%
Expenses in 2024
$16,500,278
Other
38%
Salaries & Benefits
38%
Fees to Service Providers
12%
Grants
6%
Offices, Occupancy & IT
4%
Depreciation
2%
Advertising & Promotion
<1%
Interest
<1%
Benefits to Members
0%
Revenues
2023
2024
Change
Contributions
$5,135,843
$2,710,062
-47%
Government Grants
$221,775
$267,919
+21%
Fundraising Events
$12,228
$8,760
-28%
Program Services
$11,302,981
$12,030,925
+6%
Membership Dues
$0
$0
-
Investments
$418,165
$441,647
+6%
Other
$1,153,379
$1,202,023
+4%
Total Revenues
$18,244,371
$16,661,336
-9%
Expenses
2023
2024
Change
Grants
$1,880,941
$1,026,394
-45%
Benefits to Members
$0
$0
-
Salaries & Benefits
$5,547,164
$6,245,249
+13%
Fees to Service Providers
$2,012,630
$1,951,716
-3%
Advertising & Promotion
$17,342
$8,727
-50%
Offices, Occupancy & IT
$554,736
$629,123
+13%
Interest
$2,164
$1,128
-48%
Depreciation
$286,757
$298,548
+4%
Other
$6,432,030
$6,339,393
-1%
Total Expenses
$16,733,764
$16,500,278
-1%
Net income
2023
2024
Change
Net income
+$1,510,607
+$161,058
-89%
Functional Expenses
Summary
2023
2024
Change
Program
$13,175,950
$12,536,441
-5%
Admin
$2,352,612
$2,591,767
+10%
Fundraising
$1,205,202
$1,372,070
+14%
Total Expenses
$16,733,764
$16,500,278
-1%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)